SCHEMBL6238411

SCHEMBL6238411

Cc1ccc(-c2ccc(Cl)cc2OCc2ccccc2)n1-c1cccc(S(N)(=O)=O)c1

nearest known ligand 0.75

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
PTGER1 P34995 20/20 0.75
CYP2C9 P11712 1/20 0.62

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5627829 0.94 PTGER1 (0.84) PTGER1CYP2C9
SCHEMBL6174672 0.92 PTGER1 (0.63) PTGER1CYP2C9
SCHEMBL5629779 0.86 PTGER1 (0.71) PTGER1CYP2C9
SCHEMBL14527068 0.85 PTGER1 (1.00) PTGER1CYP2C9
SCHEMBL14527501 0.84 PTGER1 (1.00) PTGER1CYP2C9
SCHEMBL5626951 0.83 PTGER1 (0.61) PTGER1CYP2C9
SCHEMBL5628732 0.80 PTGER1 (0.84) PTGER1CYP2C9
SCHEMBL5627392 0.79 PTGER1 (1.00) PTGER1CYP2C9
SCHEMBL5629224 0.78 PTGER1 (0.72) PTGER1
SCHEMBL14527502 0.78 PTGER1 (1.00) PTGER1CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1509499-A1 PYRROLE COMPOUNDS FOR THE TREATMENT OF PROSTAGLANDIN MEDIATED DISEASES GLAXO GROUP LIMITED (GB) 2005-03-02 EP disclosed
WO-2003101959-A1 PYRROLE COMPOUNDS FOR THE TREATMENT OF PROSTAGLANDIN MEDIATED DISEASES GLAXO GROUP LIMITED (GB) 2003-12-11 WO disclosed